8
62
Y.-G. HU ET AL.
4
1
2
.18 (t, J = 7.2 Hz, 2H, NCH2), 7.40–8.00 (m, 4H, Ar H). 13C NMR (100 MHz, CDCl3):
58.0, 156.9, 153.6, 142.4, 136.2, 129.3, 123.6, 122.4, 121.2, 112.7, 46.1, 32.1, 30.6, 22.0,
+
1.1, 13.6, 11.2. MS (70 eV) m/z (%): 316 (M , 36), 258 (81), 231 (51), 217 (100), 201
(
6
60), 184 (38), 158 (72), 128 (65), 101 (66). Anal. Calcd for C17H20N2O2S (316.4): C,
4.53; H, 6.37; N, 8.85. Found: C, 64.47; H, 6.31; N, 8.76.
Ethyl 2-(3-propylbenzofuro[3,2-d]pyrimidin-4(3H)-on-2-ylthio)acetate
◦
1
(
5d). White crystals, mp 142–143 C. H NMR (400 MHz, CDCl3): 1.04 (t, J = 7.2 Hz,
3
4
3
H, CH3), 1.29 (t, J = 7.2 Hz, 3H, CH3), 1.86–1.91 (m, 2H, CH2), 4.08 (s, 2H, SCH2),
.17–4.29 (q, J = 7.2 Hz, 4H, 2CH2), 7.39–7.95 (m, 4H, Ar H). MS (70 eV) m/z (%):
+
46 (M , 100), 300 (13), 260 (67), 230 (23), 202 (10), 172 (15), 130 (13). Anal. Calcd for
C17H18N2O4S (346.4): C, 58.94; H, 5.24; N, 8.09. Found: C, 58.77; H, 5.36; N, 8.01.
Methyl (2E)-3-methoxy-2-(2-{[(3-methyl-4-oxo-3,4-dihydrobenzofuro[3,
2
-d]pyrimidin-2-yl) thio]methyl}phenyl)acrylate (6a). White solid, mp 160–162
◦
1
C. H NMR (600 MHz, CDCl3): 3.62 (s, 3H, NCH3), 3.69 (s, 3H, OCH3), 3.87 (s, 3H,
OCH3), 4.58 (s, 2H, SCH2), 7.17–8.06 (m, 9H, Ar H and CH ). IR (KBr): 1700 (C O),
−1
+
1
625, 1516, 1350, 1258 cm . MS (70 eV) m/z (%): 436 (M , 9), 404 (25), 357 (8), 301
(100), 232 (20), 202 (19), 145 (99), 130 (30), 115 (34), 103 (40), 91 (8). Anal. Calcd for
C23H20N2O5S (436.5): C, 63.29; H, 4.62; N, 6.42. Found: C, 63.17, H, 4.71; N, 6.19.
Methyl (2E)-3-methoxy-2-(2-{[(3-ethyl-4-oxo-3,4-dihydrobenzofuro[3,2-
◦
d]pyrimidin-2-yl)thio] methyl}phenyl)acrylate (6b). White solid, mp 152–154 C.
1
H NMR (600 MHz, CDCl3): 1.36 (t, J = 7.2 Hz, 3H, CH3), 3.72 (s, 3H, OCH3), 3.86
(
s, 3H, OCH3), 4.24 (q, J = 7.2 Hz, 2H, NCH2), 4.56 (s, 2H, SCH2), 7.18–8.05 (m, 9H,
13
Ar H and CH ). C NMR (100 MHz, CDCl3): 167.8, 160.2, 157.8, 157.0, 153.4, 142.4,
1
36.3, 135.0, 132.9, 131.4, 130.3, 129.5, 128.2, 127.7, 123.8, 122.4, 121.3, 112.9, 110.2,
−1
62.0, 51.7, 39.9, 35.0, 13.0. IR (KBr): 1700 (C O), 1518, 1253, 1119 cm . MS (70 eV)
+
m/z (%): 450 (M , 11), 418 (17), 315 (100), 245 (10), 204 (6), 145 (44), 129 (6), 115 (10),
1
6
02 (9). Anal. Calcd for C24H22N2O5S (450.5): C, 63.98; H, 4.92; N, 6.22; Found: C,
3.79, H, 5.11; N, 6.03.
Methyl (2E)-3-methoxy-2-(2-{[(3-propyl-4-oxo-3,4-dihydrobenzofuro[3,2-
◦
d]pyrimidin-2-yl)thio] methyl}phenyl)acrylate (6c). White solid, mp 148–150 C.
1
H NMR (600 MHz, CDCl3): δ = 0.99 (t, J = 7.2 Hz, 3H, CH3), 1.77–1.81 (m, 2H, CH2),
3
.72 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 4.12 (t, J = 7.2 Hz, 2H, NCH2), 4.56 (s, 2H,
SCH2), 7.17–8.04 (m, 9H, Ar H and CH ). IR (KBr): 1688 (C O), 1632, 1518, 1253
−1
+
cm . MS (70 eV) m/z (%): 464 (M , 12), 432 (17), 329 (100), 287 (9), 259 (27), 204 (38),
1
6
45 (90), 129 (41), 115 (35), 103 (40), 91 (10). Anal. Calcd for C25H24N2O5S (464.5): C,
4.64; H, 5.21; N, 6.03. Found: C, 64.55; H, 5.32; N, 5.91.
Methyl (2E)-3-methoxy-2-(2-{[(3-butyl-4-oxo-3,4-dihydrobenzofuro[3,2-
◦
d]pyrimidin-2-yl)thio] methyl}phenyl)acrylate (6d). White solid, mp 103–105 C.
1
H NMR (600 MHz, CDCl3): δ = 0.96 (t, J = 7.2 Hz, 3H, CH3), 1.40–1.75 (m, 4H,
CH2CH2), 3.72 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 4.15 (t, J = 7.2 Hz, 2H, NCH2), 4.57
+
(
s, 2H, SCH2), 7.18–8.04 (m, 9H, Ar H and CH ). MS (70 eV) m/z (%): 478 (M , 6),
4
45 (7), 343 (100), 287 (8), 273 (10), 218 (11), 202 (15), 186 (8), 145 (32), 115 (7). Anal.
Calcd for C26H26N2O5S (478.6): C, 65.25; H, 5.48; N, 5.85. Found: C, 65.06; H, 5.36; N,
.77.
5
Methyl (2E)-3-methoxy-2-(2-{[(3-pentyl-4-oxo-3,4-dihydrobenzofuro[3,2-
◦
d]pyrimidin-2-yl)thio] methyl}phenyl)acrylate (6e). White solid, mp 92–93 C.
1
H NMR (400 MHz, CDCl3): δ = 0.91 (t, J = 7.2 Hz, 3H, CH3), 1.36–1.76 (m, 6H,
CH2CH2CH2), 3.70 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 4.14 (t, J = 7.2 Hz, 2H, NCH2),